![](/img/cover-not-exists.png)
18TiP * DESIGN OF A PHASE 2 STUDY OF BRENTUXIMAB VEDOTIN (SGN-35) AS SALVAGE THERAPY FOR MALES WITH CHEMORESISTANT GERM-CELL TUMORS (GCT)
Giannatempo, P., Anichini, A., Raggi, D., Cordareschi, E., Nicolai, N., Colecchia, M., Salvioni, R., Valagussa, P., Gianni, A., Necchi, A.Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu467.14
Date:
November, 2014
File:
PDF, 31 KB
english, 2014